The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Low-density Lipoprotein Apheresis Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Double Filtration LDL Apheresis Therapy
1.2.3 Cascade Filtration LDL Apheresis Therapy
1.3 Market by Application
1.3.1 Global Low-density Lipoprotein Apheresis Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Atherosclerosis Patient
1.3.3 Obesity Patient
1.3.4 Dyslipidemia Patient
1.3.5 Coronary Heart Disease Patient
1.3.6 Carotid Artery Disease Patient
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Low-density Lipoprotein Apheresis Therapy Market Perspective (2019-2030)
2.2 Low-density Lipoprotein Apheresis Therapy Growth Trends by Region
2.2.1 Global Low-density Lipoprotein Apheresis Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Low-density Lipoprotein Apheresis Therapy Historic Market Size by Region (2019-2024)
2.2.3 Low-density Lipoprotein Apheresis Therapy Forecasted Market Size by Region (2025-2030)
2.3 Low-density Lipoprotein Apheresis Therapy Market Dynamics
2.3.1 Low-density Lipoprotein Apheresis Therapy Industry Trends
2.3.2 Low-density Lipoprotein Apheresis Therapy Market Drivers
2.3.3 Low-density Lipoprotein Apheresis Therapy Market Challenges
2.3.4 Low-density Lipoprotein Apheresis Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Low-density Lipoprotein Apheresis Therapy Players by Revenue
3.1.1 Global Top Low-density Lipoprotein Apheresis Therapy Players by Revenue (2019-2024)
3.1.2 Global Low-density Lipoprotein Apheresis Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Low-density Lipoprotein Apheresis Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Low-density Lipoprotein Apheresis Therapy Revenue
3.4 Global Low-density Lipoprotein Apheresis Therapy Market Concentration Ratio
3.4.1 Global Low-density Lipoprotein Apheresis Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Low-density Lipoprotein Apheresis Therapy Revenue in 2023
3.5 Low-density Lipoprotein Apheresis Therapy Key Players Head office and Area Served
3.6 Key Players Low-density Lipoprotein Apheresis Therapy Product Solution and Service
3.7 Date of Enter into Low-density Lipoprotein Apheresis Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Low-density Lipoprotein Apheresis Therapy Breakdown Data by Type
4.1 Global Low-density Lipoprotein Apheresis Therapy Historic Market Size by Type (2019-2024)
4.2 Global Low-density Lipoprotein Apheresis Therapy Forecasted Market Size by Type (2025-2030)
5 Low-density Lipoprotein Apheresis Therapy Breakdown Data by Application
5.1 Global Low-density Lipoprotein Apheresis Therapy Historic Market Size by Application (2019-2024)
5.2 Global Low-density Lipoprotein Apheresis Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Low-density Lipoprotein Apheresis Therapy Market Size (2019-2030)
6.2 North America Low-density Lipoprotein Apheresis Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Low-density Lipoprotein Apheresis Therapy Market Size by Country (2019-2024)
6.4 North America Low-density Lipoprotein Apheresis Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Low-density Lipoprotein Apheresis Therapy Market Size (2019-2030)
7.2 Europe Low-density Lipoprotein Apheresis Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Low-density Lipoprotein Apheresis Therapy Market Size by Country (2019-2024)
7.4 Europe Low-density Lipoprotein Apheresis Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Size (2019-2030)
8.2 Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Low-density Lipoprotein Apheresis Therapy Market Size (2019-2030)
9.2 Latin America Low-density Lipoprotein Apheresis Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Low-density Lipoprotein Apheresis Therapy Market Size by Country (2019-2024)
9.4 Latin America Low-density Lipoprotein Apheresis Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Size (2019-2030)
10.2 Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Kaneka Pharma
11.1.1 Kaneka Pharma Company Detail
11.1.2 Kaneka Pharma Business Overview
11.1.3 Kaneka Pharma Low-density Lipoprotein Apheresis Therapy Introduction
11.1.4 Kaneka Pharma Revenue in Low-density Lipoprotein Apheresis Therapy Business (2019-2024)
11.1.5 Kaneka Pharma Recent Development
11.2 B.Braun
11.2.1 B.Braun Company Detail
11.2.2 B.Braun Business Overview
11.2.3 B.Braun Low-density Lipoprotein Apheresis Therapy Introduction
11.2.4 B.Braun Revenue in Low-density Lipoprotein Apheresis Therapy Business (2019-2024)
11.2.5 B.Braun Recent Development
11.3 Fresenius Medical Care
11.3.1 Fresenius Medical Care Company Detail
11.3.2 Fresenius Medical Care Business Overview
11.3.3 Fresenius Medical Care Low-density Lipoprotein Apheresis Therapy Introduction
11.3.4 Fresenius Medical Care Revenue in Low-density Lipoprotein Apheresis Therapy Business (2019-2024)
11.3.5 Fresenius Medical Care Recent Development
11.4 Asahi Kasei Medical
11.4.1 Asahi Kasei Medical Company Detail
11.4.2 Asahi Kasei Medical Business Overview
11.4.3 Asahi Kasei Medical Low-density Lipoprotein Apheresis Therapy Introduction
11.4.4 Asahi Kasei Medical Revenue in Low-density Lipoprotein Apheresis Therapy Business (2019-2024)
11.4.5 Asahi Kasei Medical Recent Development
11.5 Medicap
11.5.1 Medicap Company Detail
11.5.2 Medicap Business Overview
11.5.3 Medicap Low-density Lipoprotein Apheresis Therapy Introduction
11.5.4 Medicap Revenue in Low-density Lipoprotein Apheresis Therapy Business (2019-2024)
11.5.5 Medicap Recent Development
11.6 Kawasumi Laboratories
11.6.1 Kawasumi Laboratories Company Detail
11.6.2 Kawasumi Laboratories Business Overview
11.6.3 Kawasumi Laboratories Low-density Lipoprotein Apheresis Therapy Introduction
11.6.4 Kawasumi Laboratories Revenue in Low-density Lipoprotein Apheresis Therapy Business (2019-2024)
11.6.5 Kawasumi Laboratories Recent Development
11.7 Terumo Corporation
11.7.1 Terumo Corporation Company Detail
11.7.2 Terumo Corporation Business Overview
11.7.3 Terumo Corporation Low-density Lipoprotein Apheresis Therapy Introduction
11.7.4 Terumo Corporation Revenue in Low-density Lipoprotein Apheresis Therapy Business (2019-2024)
11.7.5 Terumo Corporation Recent Development
11.8 Haemonetics
11.8.1 Haemonetics Company Detail
11.8.2 Haemonetics Business Overview
11.8.3 Haemonetics Low-density Lipoprotein Apheresis Therapy Introduction
11.8.4 Haemonetics Revenue in Low-density Lipoprotein Apheresis Therapy Business (2019-2024)
11.8.5 Haemonetics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Low-density Lipoprotein Apheresis Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Double Filtration LDL Apheresis Therapy
Table 3. Key Players of Cascade Filtration LDL Apheresis Therapy
Table 4. Global Low-density Lipoprotein Apheresis Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Low-density Lipoprotein Apheresis Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Low-density Lipoprotein Apheresis Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Low-density Lipoprotein Apheresis Therapy Market Share by Region (2019-2024)
Table 8. Global Low-density Lipoprotein Apheresis Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Low-density Lipoprotein Apheresis Therapy Market Share by Region (2025-2030)
Table 10. Low-density Lipoprotein Apheresis Therapy Market Trends
Table 11. Low-density Lipoprotein Apheresis Therapy Market Drivers
Table 12. Low-density Lipoprotein Apheresis Therapy Market Challenges
Table 13. Low-density Lipoprotein Apheresis Therapy Market Restraints
Table 14. Global Low-density Lipoprotein Apheresis Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Low-density Lipoprotein Apheresis Therapy Market Share by Players (2019-2024)
Table 16. Global Top Low-density Lipoprotein Apheresis Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Low-density Lipoprotein Apheresis Therapy as of 2023)
Table 17. Ranking of Global Top Low-density Lipoprotein Apheresis Therapy Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Low-density Lipoprotein Apheresis Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Low-density Lipoprotein Apheresis Therapy Product Solution and Service
Table 21. Date of Enter into Low-density Lipoprotein Apheresis Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Low-density Lipoprotein Apheresis Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Low-density Lipoprotein Apheresis Therapy Revenue Market Share by Type (2019-2024)
Table 25. Global Low-density Lipoprotein Apheresis Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Low-density Lipoprotein Apheresis Therapy Revenue Market Share by Type (2025-2030)
Table 27. Global Low-density Lipoprotein Apheresis Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Low-density Lipoprotein Apheresis Therapy Revenue Market Share by Application (2019-2024)
Table 29. Global Low-density Lipoprotein Apheresis Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Low-density Lipoprotein Apheresis Therapy Revenue Market Share by Application (2025-2030)
Table 31. North America Low-density Lipoprotein Apheresis Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Low-density Lipoprotein Apheresis Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Low-density Lipoprotein Apheresis Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Low-density Lipoprotein Apheresis Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Low-density Lipoprotein Apheresis Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Low-density Lipoprotein Apheresis Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Low-density Lipoprotein Apheresis Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Low-density Lipoprotein Apheresis Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Low-density Lipoprotein Apheresis Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 46. Kaneka Pharma Company Detail
Table 47. Kaneka Pharma Business Overview
Table 48. Kaneka Pharma Low-density Lipoprotein Apheresis Therapy Product
Table 49. Kaneka Pharma Revenue in Low-density Lipoprotein Apheresis Therapy Business (2019-2024) & (US$ Million)
Table 50. Kaneka Pharma Recent Development
Table 51. B.Braun Company Detail
Table 52. B.Braun Business Overview
Table 53. B.Braun Low-density Lipoprotein Apheresis Therapy Product
Table 54. B.Braun Revenue in Low-density Lipoprotein Apheresis Therapy Business (2019-2024) & (US$ Million)
Table 55. B.Braun Recent Development
Table 56. Fresenius Medical Care Company Detail
Table 57. Fresenius Medical Care Business Overview
Table 58. Fresenius Medical Care Low-density Lipoprotein Apheresis Therapy Product
Table 59. Fresenius Medical Care Revenue in Low-density Lipoprotein Apheresis Therapy Business (2019-2024) & (US$ Million)
Table 60. Fresenius Medical Care Recent Development
Table 61. Asahi Kasei Medical Company Detail
Table 62. Asahi Kasei Medical Business Overview
Table 63. Asahi Kasei Medical Low-density Lipoprotein Apheresis Therapy Product
Table 64. Asahi Kasei Medical Revenue in Low-density Lipoprotein Apheresis Therapy Business (2019-2024) & (US$ Million)
Table 65. Asahi Kasei Medical Recent Development
Table 66. Medicap Company Detail
Table 67. Medicap Business Overview
Table 68. Medicap Low-density Lipoprotein Apheresis Therapy Product
Table 69. Medicap Revenue in Low-density Lipoprotein Apheresis Therapy Business (2019-2024) & (US$ Million)
Table 70. Medicap Recent Development
Table 71. Kawasumi Laboratories Company Detail
Table 72. Kawasumi Laboratories Business Overview
Table 73. Kawasumi Laboratories Low-density Lipoprotein Apheresis Therapy Product
Table 74. Kawasumi Laboratories Revenue in Low-density Lipoprotein Apheresis Therapy Business (2019-2024) & (US$ Million)
Table 75. Kawasumi Laboratories Recent Development
Table 76. Terumo Corporation Company Detail
Table 77. Terumo Corporation Business Overview
Table 78. Terumo Corporation Low-density Lipoprotein Apheresis Therapy Product
Table 79. Terumo Corporation Revenue in Low-density Lipoprotein Apheresis Therapy Business (2019-2024) & (US$ Million)
Table 80. Terumo Corporation Recent Development
Table 81. Haemonetics Company Detail
Table 82. Haemonetics Business Overview
Table 83. Haemonetics Low-density Lipoprotein Apheresis Therapy Product
Table 84. Haemonetics Revenue in Low-density Lipoprotein Apheresis Therapy Business (2019-2024) & (US$ Million)
Table 85. Haemonetics Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Low-density Lipoprotein Apheresis Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Low-density Lipoprotein Apheresis Therapy Market Share by Type: 2023 VS 2030
Figure 3. Double Filtration LDL Apheresis Therapy Features
Figure 4. Cascade Filtration LDL Apheresis Therapy Features
Figure 5. Global Low-density Lipoprotein Apheresis Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Low-density Lipoprotein Apheresis Therapy Market Share by Application: 2023 VS 2030
Figure 7. Atherosclerosis Patient Case Studies
Figure 8. Obesity Patient Case Studies
Figure 9. Dyslipidemia Patient Case Studies
Figure 10. Coronary Heart Disease Patient Case Studies
Figure 11. Carotid Artery Disease Patient Case Studies
Figure 12. Low-density Lipoprotein Apheresis Therapy Report Years Considered
Figure 13. Global Low-density Lipoprotein Apheresis Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Low-density Lipoprotein Apheresis Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Low-density Lipoprotein Apheresis Therapy Market Share by Region: 2023 VS 2030
Figure 16. Global Low-density Lipoprotein Apheresis Therapy Market Share by Players in 2023
Figure 17. Global Top Low-density Lipoprotein Apheresis Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Low-density Lipoprotein Apheresis Therapy as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Low-density Lipoprotein Apheresis Therapy Revenue in 2023
Figure 19. North America Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Low-density Lipoprotein Apheresis Therapy Market Share by Country (2019-2030)
Figure 21. United States Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Low-density Lipoprotein Apheresis Therapy Market Share by Country (2019-2030)
Figure 25. Germany Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Share by Region (2019-2030)
Figure 33. China Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Low-density Lipoprotein Apheresis Therapy Market Share by Country (2019-2030)
Figure 41. Mexico Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Share by Country (2019-2030)
Figure 45. Turkey Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Kaneka Pharma Revenue Growth Rate in Low-density Lipoprotein Apheresis Therapy Business (2019-2024)
Figure 48. B.Braun Revenue Growth Rate in Low-density Lipoprotein Apheresis Therapy Business (2019-2024)
Figure 49. Fresenius Medical Care Revenue Growth Rate in Low-density Lipoprotein Apheresis Therapy Business (2019-2024)
Figure 50. Asahi Kasei Medical Revenue Growth Rate in Low-density Lipoprotein Apheresis Therapy Business (2019-2024)
Figure 51. Medicap Revenue Growth Rate in Low-density Lipoprotein Apheresis Therapy Business (2019-2024)
Figure 52. Kawasumi Laboratories Revenue Growth Rate in Low-density Lipoprotein Apheresis Therapy Business (2019-2024)
Figure 53. Terumo Corporation Revenue Growth Rate in Low-density Lipoprotein Apheresis Therapy Business (2019-2024)
Figure 54. Haemonetics Revenue Growth Rate in Low-density Lipoprotein Apheresis Therapy Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed